Combined BRAF and MEK Inhibition with Dabrafenib and Trametinib in BRAF V600-mutant colorectal cancer

被引：0
|
作者：
Loir, E. [1 ]
Cochereau, D. [1 ]
机构：
[1] AERIO, Paris, France
来源：
ONCOLOGIE | 2016年 / 18卷 / 9-10期
关键词：
IMPROVED SURVIVAL; VEMURAFENIB; MELANOMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [21] Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma
    Hargrave, Darren R.
    Terashima, Keita
    Hara, Junichi
    Kordes, Uwe R.
    Upadhyaya, Santhosh A.
    Sahm, Felix
    Bouffet, Eric
    Packer, Roger J.
    Witt, Olaf
    Sandalic, Larissa
    Kieloch, Agnieszka
    Russo, Mark
    Cohen, Kenneth J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (33) : 5174 - +
  • [22] Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma
    Balasubramanian, Adithya
    Gunjur, Ashray
    Gan, Hui Kong
    Perchyonok, Yuliya
    Cher, Lawrence Myron
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 79 : 269 - 271
  • [23] Combined BRAF and MEK inhibition in BRAF-mutant NSCLC
    Rivalland, Gareth
    Mitchell, Paul
    [J]. LANCET ONCOLOGY, 2016, 17 (07): : 860 - 862
  • [24] BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer
    Ros, Javier
    Baraibar, Iosune
    Sardo, Emilia
    Mulet, Nuria
    Salva, Francesc
    Argiles, Guillem
    Martini, Giulia
    Ciardiello, Davide
    Cuadra, Jose Luis
    Tabernero, Josep
    Elez, Elena
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [25] Combined BRAF, EGFR, and MEK Inhibition in Patients with &ITBRAF&ITV600E-Mutant Colorectal Cancer
    Corcoran, Ryan B.
    Andre, Thierry
    Atreya, Chloe E.
    Schellens, Jan H. M.
    Yoshino, Takayuki
    Bendell, Johanna C.
    Hollebecque, Antoine
    McRee, Autumn J.
    Siena, Salvatore
    Middleton, Gary
    Muro, Kei
    Gordon, Michael S.
    Tabernero, Josep
    Yaeger, Rona
    O'Dwyer, Peter J.
    Humblet, Yves
    De Vos, Filip
    Jung, A. Scott
    Brase, Jan C.
    Jaeger, Savina
    Bettinger, Severine
    Mookerjee, Bijoyesh
    Rangwala, Fatima
    Van Cutsem, Eric
    [J]. CANCER DISCOVERY, 2018, 8 (04) : 428 - 443
  • [26] Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Marks, Asher M.
    Bindra, Ranjit S.
    DiLuna, Michael L.
    Huttner, Anita
    Jairam, Vikram
    Kahle, Kristopher T.
    Kieran, Mark W.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 (05)
  • [27] Phase 1-2 trial of the BRAF inhibitor dabrafenib (D) plus MEK inhibitor trametinib (T) in BRAF V600 mutant colorectal cancer (CRC): Updated efficacy and biomarker analysis.
    Corcoran, Ryan Bruce
    Atreya, Chloe Evelyn
    Falchook, Gerald Steven
    Infante, Jeffrey R.
    Hamid, Omid
    Messersmith, Wells A.
    Daud, Adil
    Kwak, Eunice Lee
    Ryan, David
    Kurzrock, Razelle
    Sun, Peng
    Cunningham, Elizabeth Ann
    Orford, Keith W.
    Motwani, Monica
    Bai, Yuchen
    Patel, Kiran
    Venook, Alan P.
    Kopetz, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Comment on: Response to the BRAF/MEK inhibitors dabrafenib/trametinib in an adolescent with a BRAF V600E mutated anaplastic ganglioglioma intolerant to vemurafenib
    Bourque, Melissa S.
    Salek, Marta
    Sabin, Noah D.
    Canale, Meredith
    Upadhyaya, Santhosh A.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (04)
  • [29] Characterizing mechanisms of BRAF/MEK inhibitor resistance in BRAF V600 mutant colorectal cancer vs. melanoma
    Maxwell, Jennifer
    Rousselle, Emmanuelle
    An, Lucy
    Rose, April
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [30] Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma
    Si, Lu
    Zhang, Xiaoshi
    Shin, Sang Joon
    Fan, Yun
    Lin, Chia-Chi
    Kim, Tae Min
    Dechaphunkul, Arunee
    Maneechavakajorn, Jedzada
    Wong, Chi Sing
    Ilankumaran, Palanichamy
    Lee, Dung-Yang
    Gasal, Eduard
    Li, Haifu
    Guo, Jun
    [J]. EUROPEAN JOURNAL OF CANCER, 2020, 135 : 31 - 38
12345